LARVOL (@Larvol) / X

LARVOL

7,055 posts

LARVOL

@Larvol

At the intersection of #AI & #Oncology data. We provide clinical intelligence, trial insights & competitive analysis for #Pharmaceutical & #BioTech.

United States

Joined April 2009

Pinned
LARVOL
@Larvol
Mar 4, 2025
How is AI revolutionizing oncology data? Find out in this special 'New Frontiers' episode (aired on Bloomberg) that explores the evolution of AI-powered oncology Data Intelligence with @Larvol. #LARVOL #BloombergTV #NewFrontiers #Tech #Healthcare #Oncology #CancerResearch
00:00
30K
LARVOL
@Larvol
Mar 2, 2022
Great podcast with our friend, entrepreneur @NeilPassero talking creating culture through purpose, energy, creativity and connection.
LARVOL
@Larvol
Dec 26, 2024
@Larvol CLIN highlights top papers for 2024 in GI Cancer research based on reactions from 5,000 oncologists on X. #LARVOL #Oncology #GICancer #CancerResearch #OncologyUpdates #CancerData #ClinicalTrials
51K
LARVOL
@Larvol
Dec 24, 2024
Here are the Top 10 Most Active Cancer Institutes that are leading the conversation in innovation and insights, ranked based on oncologists' reactions and engagement on X (formerly Twitter). #LARVOL #CancerResearch #Oncology #OncologyInsights #CancerData
32K
LARVOL
@Larvol
Jul 16, 2021
Based on data presented during #ESMOVirtualplenary, should #pembro be considered SOC for early stage #TNBC or wait for OS data?
Yes, SOC36.7%
No, wait for OS46.8%
Other16.5%
79 votesFinal results
LARVOL
@Larvol
Sep 25, 2024
@Larvol Onco Data Podcast with @SuyogCancer & @sonpavde | @myESMO x.com/i/broadcasts/1…
15K
LARVOL
@Larvol
Dec 25, 2024
The 2024 edition of the Top 100 Oncologists on X is here! This list is created based on peer-nomination and measure of influence on social media, among over 5000 oncologists. #LARVOL #Oncology #CancerResearch #OncologyInsights #CancerData
25K
LARVOL
@Larvol
Dec 24, 2024
Meet the women on X changing the face of oncology. These peer-nominated oncologists are not just socially influential but deeply inspiring. Let’s celebrate their brilliance! #LARVOL #CancerResearch #Oncology #OncologyInsights #OncologyUpdates #CancerCare #CancerData
14K
LARVOL
@Larvol
Oct 7, 2025
Top Cancer Institutes on X in Q3 2025, based on oncologists' posts and views. Explore more about oncology conferences, top trials, and reactions from oncologists: clin.larvol.com #LARVOL #Oncology #CancerResearch #CancerData #CancerCare #OncologyUpdates
10K
LARVOL
@Larvol
Jul 23, 2021
Do you think that patients who are treated with anti-PD1 should receive a booster vaccine for COVID19?
Yes58.7%
No41.3%
259 votesFinal results
LARVOL
@Larvol
May 9, 2023
#AI has the power to transform #healthcare, especially for underserved communities. Discover how, as Jason Howard, Medical Digital Lead at Sanofi, sheds light on its potential to improve accessibility in underserved communities. #HealthcareInnovation #Pathology #MedicalAI
00:00
56K
LARVOL
@Larvol
Dec 23, 2024
@Larvol CLIN - Building In Public | Ep 12: Join @brunolarvol and @sweta_agrw to explore how #LARVOL CLIN tracks insights from 5,000 oncologists and highlights key trials from @SABCSSanAntonio 2024. Join us now: t.ly/sBlwV #SABCS24 #BreastCancer #Oncology
2.2K
LARVOL
@Larvol
Sep 9, 2025
🔄 Refreshed FLAURA2 data from @IASLC-WCLC25 in EGFR-mutant NSCLC landscape from Dr. Akhil Santhosh (@tuttsakhil) A side-by-side look at FLAURA, FLAURA2, MARIPOSA & PAPILLON shaping the 1L treatment landscape. 📊 Image ⬇️ x.com/tuttsakhil/sta… And, explore more insights and
Dr Akhil Santhosh MD DM MRCP(UK)
@tuttsakhil
Jan 25, 2025
Quick revision slide: Phase 3 1st line trials in EGFR mutated advanced NSCLC
12K
LARVOL
@Larvol
Dec 26, 2024
Discover the Top Research Papers in Lung Cancer for 2024, curated by @Larvol CLIN based on the sentiments among 5,000 oncologists on X. #LARVOL #Oncology #LungCancer #CancerResearch #OncologyUpdates #CancerData #ClinicalTrials
7.1K